Immunitybio Share Price (NASDAQ: IBRX)
$2.33
Live
Last updated on
Check the interactive Immunitybio Stock chart to analyse performance
Immunitybio stock performance
as on August 28, 2025 at 12:36 am IST
- Today's Low:$2.33Today's High:$2.41
0.0%
Downside
Day's Volatility :3.32%
Upside
3.32%
- 52 Weeks Low:$1.8352 Weeks High:$7.48
21.46%
Downside
52 Weeks Volatility :75.53%
Upside
68.85%
Immunitybio Stock Returns
Immunitybio Inc. Key Stats
Check Immunitybio key stats like market cap, P/E ratio, EPS, Dividend Yield, and more.
Stock Returns calculator for Immunitybio Stock including INR - Dollar returns
The Immunitybio stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Immunitybio investment value today
Current value as on today
₹60,282
Returns
Returns from Immunitybio Stock
Dollar Returns*
₹4,673 (+4.67%)
Indian investors sentiment towards Immunitybio Stock
Global Institutional Holdings in Immunitybio Inc.
Name
Holdings %
Vanguard Group Inc
2.31%
BlackRock Inc
1.41%
Armistice Capital, LLC
0.82%
State Street Corp
0.80%
Geode Capital Management, LLC
0.45%
Woodline Partners LP
0.36%
Analyst Recommendation on Immunitybio Stock
Buy
75%Buy
25%Hold
0%Sell
Based on 8 Wall street analysts offering stock ratings for Immunitybio(by analysts ranked 0 to 5 stars)
- Current
- 1M Ago
- 3M Ago
Immunitybio Share Price Target
What analysts predicted
Upside of 337.77%
Target:
$10.20
Current:
$2.33
Immunitybio share price target is $10.20, a slight Upside of 337.77% compared to current price of $2.33 as per analysts' prediction.
Immunitybio Stock Insights
Price Movement
In the last 1 month, IBRX stock has moved down by -17.0%Increasing Revenue
Revenue is up for the last 6 quarters, 40.0K → 26.42M (in $), with an average increase of 58.0% per quarterIncreasing Net Profit
Netprofit is up for the last 2 quarters, -129.64M → -92.55M (in $), with an average increase of 40.1% per quarterIBRX vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 61.0% return, outperforming this stock by 104.3%IBRX vs ALNY (3 yr)
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 113.9% return, outperforming this stock by 155.8%Price to Sales
ForIBRX every $1 of sales, investors are willing to pay $33.5, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $23.7 for every $1 of sales.
Immunitybio Inc. Financials
Immunitybio Technicals Summary
Sell
Neutral
Buy
Immunitybio is currently in a neutral trading position according to technical analysis indicators.
Immunitybio Inc. Vs Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
| -10.38% | -20.83% | -43.32% | -39.41% | -92.69% |
 | 5.16% | -16.9% | -51.12% | -0.89% | -2.51% |
 | 4.54% | 18.87% | 52.28% | 84.02% | 26.72% |
 | -16.02% | -19.22% | -19.42% | 37.43% | 43.36% |
 | 38.9% | 84.99% | 60.96% | 115.82% | 243.29% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
| NA | NA | NA | -0.47 | 0.0 | -0.42 | NA | -0.62 |
| 14.86 | 14.86 | 1.21 | 39.42 | 0.15 | 0.07 | 0.0 | 287.55 |
| NA | NA | NA | 2.29 | -0.05 | -0.01 | NA | 34.32 |
| 27.64 | 27.64 | 0.58 | 18.06 | 0.23 | 0.13 | NA | 67.02 |
| NA | NA | -0.49 | 3.92 | -2.58 | -0.03 | NA | 1.91 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
| Buy | $2.2B | -92.69% | NA | 0.0% |
| Buy | $62.5B | -2.51% | 14.86 | 31.37% |
| NA | $38.3B | 26.72% | NA | -3.89% |
| Buy | $99.7B | 43.36% | 27.64 | 31.86% |
| Buy | $58.2B | 243.29% | NA | -12.96% |
Immunitybio Dividend announcements
Immunitybio Earnings
Immunitybio’s price-to-earnings ratio stands at None
About Immunitybio Inc.
Key Management of Immunitybio Inc.
Important FAQs about investing in IBRX Stock from India :
What is Immunitybio share price today?
Immunitybio share price today is $2.33 as on . Immunitybio share today touched a day high of $2.41 and a low of $2.33.
What is the 52 week high and 52 week low for Immunitybio share?
Immunitybio share touched a 52 week high of $7.48 and a 52 week low of $1.83. Immunitybio stock price today i.e. is trending at $2.33, lower by 68.85% versus the 52 week high.
How to invest in Immunitybio Stock (IBRX) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Immunitybio on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immunitybio Shares that will get you 0.6438 shares as per Immunitybio share price of $2.33 per share as on August 28, 2025 at 12:36 am IST.
What is the minimum amount required to buy Immunitybio Stock (IBRX) from India?
Indian investors can start investing in Immunitybio (IBRX) shares with as little as ₹87.86 or $1 (as of August 27, 2025) using the INDmoney app.
For example: If you want to invest $10 or ₹878.60 in Immunitybio stock (as per the Rupee-Dollar exchange rate as on August 27, 2025).
Based on Immunitybio share’s latest price of $2.33 as on August 28, 2025 at 12:36 am IST, you will get 4.2918 shares of Immunitybio. Learn more about
fractional shares .
What are the returns that Immunitybio has given to Indian investors in the last 5 years?
Immunitybio stock has given -92.69% share price returns and 18.89% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?
Discover More
Xenon Pharmaceuticals Inc$38.68
+0.08%
Penumbra Inc$269.07
+1.15%
Ufp Technologies Inc$213.93
-2.06%
Hutchison China Meditech Limited$14.96
-4.29%
Vaxcyte Inc$30.25
+0.0%
Agios Pharmaceuticals, Inc.$39.43
+2.52%
Radnet Inc$71.25
+0.96%
Grifols, S.a.$9.82
-0.2%
Acadia Pharmaceuticals Inc.$26.25
+2.06%